Alliance Pharma Share Price | |
---|---|
Price | 34.00 |
Bid | 33.95 |
Ask | 34.00 |
Change | -0.95 (-2.72%) |
Volume | 3,813,218 |
Open | 35.00 |
High | 35.00 |
Low | 33.95 |
Prev. Close | 34.95 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £183.74m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 383 |
---|---|
Vol. Sold | 330,621 |
Sold Value | £113.21k |
Vol. Bought | 3,637,597 |
Bought Value | £1.25m |
PE Ratio | 200.00 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.974% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
29-Apr-24 | 16:36:21 | 34.00 | 25,000 | Buy* | 33.95 | 34.00 | 8,500 | O Ordinary |
29-Apr-24 | 16:35:22 | 34.00 | 121,596 | Buy* | 33.95 | 34.00 | 41.34k | UT Uncrossing Trade |
29-Apr-24 | 16:29:59 | 33.95 | 593 | Sell* | 33.95 | 34.00 | 201.32 | A Automatic Execution |
29-Apr-24 | 16:29:59 | 33.95 | 199 | Sell* | 33.95 | 34.00 | 67.56 | A Automatic Execution |
29-Apr-24 | 16:29:58 | 34.00 | 206 | Buy* | 33.95 | 34.00 | 70.04 | A Automatic Execution |
29-Apr-24 | 16:29:58 | 34.00 | 12,879 | Buy* | 33.95 | 34.00 | 4,379 | A Automatic Execution |
29-Apr-24 | 16:29:58 | 34.00 | 699 | Sell* | 33.95 | 34.65 | 237.66 | A Automatic Execution |
29-Apr-24 | 16:29:58 | 34.00 | 2,595 | Buy* | 33.95 | 34.00 | 882.30 | A Automatic Execution |
29-Apr-24 | 16:29:56 | 34.00 | 4,523 | Buy* | 33.95 | 34.00 | 1,538 | A Automatic Execution |
29-Apr-24 | 16:29:52 | 34.171 | 475,000 | Buy* | 33.95 | 34.00 | 162.31k | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions